SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical?stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, announced today that members of its senior management team will present and participate the following upcoming investor conferences:
- TD Cowen's 44th Annual Health Care Conference on Monday, March 4th at 11:10 am Eastern Time
- H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference on March 26th at 3:30 pm Eastern Time
A live webcast of the ...